Alphaviruses are small enveloped RNA viruses that include important emerging human pathogens, such as chikungunya virus (CHIKV). These viruses infect cells via a low-pH-triggered membrane fusion reaction, making this step a potential target for antiviral therapies. The E1 fusion protein inserts into the target membrane, trimerizes, and refolds to a hairpin-like conformation in which the combination of E1 domain III (DIII) and the stem region (DIII-stem) pack against a core trimer composed of E1 domains I and II (DI/II). Addition of exogenous DIII proteins from Semliki Forest virus (SFV) has been shown to inhibit E1 hairpin formation and SFV fusion and infection. Here we produced and characterized DIII and DI/II proteins from CHIKV and SFV. Unlike SFV DIII, both core trimer binding and fusion inhibition by CHIKV DIII required the stem region. CHIKV DIIIstem and SFV DIII-stem showed efficient cross-inhibition of SFV, Sindbis virus, and CHIKV infections. We developed a fluorescence anisotropy-based assay for the binding of SFV DIII-stem to the core trimer and used it to demonstrate the relatively high affinity of this interaction (K d [dissociation constant], ϳ85 nM) and the importance of the stem region. Together, our results support the conserved nature of the key contacts of DIII-stem in the alphavirus E1 homotrimer and describe a sensitive and quantitative in vitro assay for this step in fusion protein refolding.
The Alphavirus genus contains about 40 recognized species of small enveloped plus-sense RNA viruses (1, 2). Most alphaviruses are transmitted by mosquito vectors and can infect a variety of mammalian, avian, and other hosts. Alphaviruses can produce fever, arthritis, and encephalitis in humans and include potential bioterrorism agents and emerging infectious disease threats, such as Venezuelan, Eastern, and Western equine encephalitis viruses and chikungunya virus (CHIKV). Recent outbreaks caused millions of CHIKV infections in south India and on La Reunion and other islands in the Indian Ocean (3, 4). Although past epidemics of CHIKV have been confined to Africa and Asia, increased air travel has produced increased transmission in Europe and the Western hemisphere (4-6). A mutation enhancing the ability of CHIKV to infect and be transmitted by the Aedes albopictus mosquito has also increased the risk for infection due to the continuing global spread of this vector (7-9). There are currently no approved vaccines or antiviral therapies for CHIKV infection.Alphaviruses infect cells by binding to cell surface receptors, internalization by endocytosis, and low-pH-triggered fusion of the viral and endosomal membranes (reviewed in references 1 and 10). Similarly, CHIKV infection has been shown to require endocytic uptake and low pH (11). Fusion and infection by alphaviruses, such as Semliki Forest virus (SFV) and Sindbis virus (SINV), are promoted by cholesterol in the host cell membrane (12-16), and studies of CHIKV suggest that its infection is also promoted by cholesterol (11,17).The alphavirus membrane i...